Loading...

TheraVet SA

ALVET.PAEURONEXT
Healthcare
Biotechnology
0.08
0.00(0.00%)

TheraVet SA (ALVET.PA) Company Profile & Overview

Explore TheraVet SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

TheraVet SA (ALVET.PA) Company Profile & Overview

TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.

SectorHealthcare
IndustryBiotechnology
CEOGaetan Terrasse

Contact Information

Rue d'Edimbourg 11b, Charleroi, 6040

Company Facts

5 Employees
IPO DateJun 17, 2021
CountryBE

Frequently Asked Questions

;